MM+M today debuted its 2024 Women of Distinction and Women to Watch award programs.
Entering their ninth year, the MM+M Women of Distinction and Women to Watch programs celebrate healthcare marketing executives who have significantly impacted their organizations — and the industry writ large — during the past year. Eligible organizations include biopharma companies, medical device and diagnostics firms, healthcare marketing and communications agencies and health media entities.
In the past, Women of Distinction honorees have typically served in one of several top leadership roles, including CEO, president, chair, EVP, SVP and managing director. Woman to Watch honorees have most often served in mid- to top-level roles, including VP, senior account director, account executive and account director.
“Year in and year out, we’re blown away by the caliber of Women of Distinction and Women to Watch nominees,” said MM+M editor-in-chief Larry Dobrow. “It’s a privilege to shine a spotlight on their achievements. We’ve said it before and we’ll say it again: They represent the best of what the medical marketing business has to offer.”
The first nomination deadline for the Women of Distinction and Women to Watch programs is January 10. MM+M will reveal the honorees in March and they will be celebrated at an event scheduled for June 13 in New York City.
For questions about nomination eligibility as well as the Women of Distinction/Women to Watch event, please reach out to MM+M’s Jenny Abramczyk.
To read more about the Women of Distinction program and its final deadline, click here.
